Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / California

Peptide legality · California · updated 2026-09-21

Are peptides legal in California?

Restricted

Restricted: California layers active state enforcement and compounding rules that go beyond the federal baseline on top of federal drug law, so most research-grade peptides are unlawful for human use in California and compounded GLP-1 access has narrowed sharply.

Legal status overview

California is restricted. The state defers to federal drug law but has also codified compounding standards that exceed the federal floor and both the California State Board of Pharmacy and the Medical Board of California actively inspect and prosecute clinics that use peptides labeled for research use only. Prescription peptides dispensed by a licensed provider through a properly licensed compounding pharmacy can be lawful, while selling or administering research-chemical peptides for human consumption is treated as a clear violation. FDA-approved branded GLP-1 medicines remain fully legal with a prescription, but the pathway for compounded copies has largely closed since the shortages resolved.

Key points

  • California is the only state that has adopted codified compounding standards exceeding federal requirements for compounded GLP-1s and peptides, with comprehensively revised rules that took effect in 2025 at Title 16 of the California Code of Regulations, sections 1735 and following. [1]
  • The California State Board of Pharmacy requires a pharmacist to verify and document a clinically significant, patient-specific justification before compounding, and inspectors have been flagging compounded GLP-1 products during routine pharmacy surveys. [1]
  • Advertising, administering, or selling peptides labeled for research use only, such as BPC-157, TB-500, or research-grade semaglutide, for human consumption is treated as a violation of federal and state law in California, and the Medical Board of California and Board of Pharmacy prosecute clinics that use non-pharmaceutical active ingredients. [6]
  • BPC-157 and TB-500 are not FDA-approved for human use, are not scheduled narcotics, and the research use only label on a vial provides no legal cover when the substance is used in the body. [4]
  • After the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, the FDA ended enforcement discretion for compounders, so 503A pharmacies generally may not compound copies of these drugs beyond a narrow four-or-fewer-prescriptions-per-month exception. Compounded semaglutide and tirzepatide are not FDA-approved, are not a generic, and were not evaluated by the FDA. [2]
  • The FDA ended 503A enforcement discretion for tirzepatide by March 19, 2025, and for semaglutide on April 22, 2025, with 503B outsourcing facilities for semaglutide following on May 22, 2025. [5]
  • Growth-hormone peptides tie into somatropin, which is not a controlled substance but is separately restricted under federal law at 21 U.S.C. 333(e), which makes distribution for non-approved purposes such as bodybuilding a felony. [7]
  • Prescription peptides are generally allowed in California only when prescribed by a licensed provider and dispensed by a compounding pharmacy licensed to operate or ship into the state, reflecting a prescription-and-pharmacy-gated framework rather than open retail sale. [6]

Compound-by-compound status

BPC-157
Restricted
Not FDA-approved for human use and not a scheduled narcotic, but selling or administering it as a research chemical for human consumption is actively prosecuted in California by the Board of Pharmacy and Medical Board.
GLP-1 class (Ozempic® / Wegovy® semaglutide; Mounjaro® / Zepbound® tirzepatide)
Restricted
FDA-approved branded products are fully legal with a prescription. Compounded versions are not FDA-approved, are not a generic, and were not evaluated by the FDA, and the compounding pathway largely closed after the 2024 to 2025 shortages resolved, with California adding documentation rules beyond the federal floor.
TB-500 (thymosin beta-4)
Restricted
Not FDA-approved for human use. Like BPC-157, its research use only labeling gives no legal cover, and human-use sale or administration draws California enforcement.
Growth hormone / somatropin
Restricted
A prescription drug that is not a controlled substance, but federal law at 21 U.S.C. 333(e) makes distribution for non-approved uses a felony, and growth-hormone-stimulating peptides are lawful in California only through a prescription filled by a licensed compounding pharmacy.

Frequently asked questions

Are peptides legal in California?

It depends on the peptide and how it is obtained. FDA-approved peptide medicines and validly prescribed compounded peptides dispensed by a licensed compounding pharmacy can be lawful, while peptides labeled for research use only, such as BPC-157 or TB-500, are treated as unlawful when used for human consumption, and California actively enforces against clinics that use them.

Can I still get compounded semaglutide or tirzepatide in California?

Access has narrowed a lot. After the shortages resolved and the FDA ended enforcement discretion in 2025, 503A pharmacies generally cannot compound copies of these drugs except for a narrow four-or-fewer-prescriptions-per-month exception. Wegovy® (semaglutide), Ozempic® (semaglutide), Mounjaro® (tirzepatide), and Zepbound® (tirzepatide) remain available with a prescription.

Is BPC-157 legal to buy in California?

BPC-157 is not FDA-approved for human use and is not a scheduled narcotic, so vials are often sold labeled research use only. That label does not make it legal to put in your body, and California regulators prosecute clinics that administer it for human consumption. This is legal information, not medical or legal advice.

Does California have stricter rules than federal law?

Yes. California has codified compounding standards that exceed the federal baseline, including a requirement that pharmacists document a clinically significant, patient-specific justification before compounding, and its Board of Pharmacy and Medical Board conduct inspections and enforcement.

Are growth-hormone peptides legal in California?

Somatropin and growth-hormone-stimulating peptides are prescription-only. Somatropin is not a controlled substance, but federal law makes distributing it for non-approved purposes a felony, so these substances are lawful in California only through a valid prescription filled by a licensed pharmacy.

General information based on the sourced research above, not legal advice. For a specific situation in California, consult a licensed attorney familiar with pharmaceutical law.